Symbios Announces Patent Award for Plasma Oxidation Technology

Share Article

Symbios’ dynamic plasma activation technology protected for use in manufacturing, healthcare, utility, and oil and gas markets

Symbios Technologies

This is an important milestone for our company and we are proud of the acknowledgement and protection of our intellectual property provided by this patent award from the USPTO,” said Justin Bzdek, president and CEO, Symbios Technologies.

Symbios Technologies, Inc., a world-leading developer of dynamic aqueous plasma technology platforms, announced today that United States Patent and Trademark Office (USPTO) has awarded the company a patent for its tubular high-density plasma reactor, U.S. Patent # 9,346,691.

The Symbios Tubular Plasma Reactor™ (TPR4000™) provides improved, lower-cost oxidation methods for ultrapure, process, and wastewater applications by simultaneously eliminating organic and microbial contamination without the need for added chemicals or producing a waste stream. The groundbreaking design of the TPR4000 combines a continuous mixing mechanism with an air-enhanced plasma discharge system.

“This is an important milestone for our company and we are proud of the acknowledgement and protection of our intellectual property provided by this patent award from the USPTO,” said Justin Bzdek, president and CEO, Symbios. “The TPR’s innovative design and impressive economics as an advanced plasma oxidation system for fluid treatment also enables it to be quickly tuned for application in food & beverage, healthcare, power plant, fracking wastewater treatment, and other industrial and municipal markets.”

The TPR4000 is the only technology that combines the action and chemistry of UV, ozone, peroxide, and chlorine-based technologies all in one system providing superior efficacy and lower cost vs. alternative advanced oxidation processes.

“This cornerstone patent award is part of an ever expanding portfolio of innovation and patent submissions that highlights our capabilities to address the needs of our industrial partners, with technology made possible by research funded by the National Science Foundation (NSF) Small Business Innovation Research (SBIR) Program,” concluded Bzdek.

About Symbios Technologies

Symbios Technologies, Inc. is a world-leading developer of dynamic aqueous plasma technology platforms for water treatment, specialty manufacturing, and biotherapeutic applications. The company, working with its university, government and industrial partners is commercializing its disruptive advanced low-cost aqueous plasma oxidation technology, the Symbios Tubular Plasma Reactor™ (TPR4000™), to clean water, preserve the environment, and protect human health as well as improve production economics and sustainability. Symbios Technologies’ modular reactor is low in capital cost, able to replace existing energy-hungry or poor-performing advanced oxidation processes, reduce or eliminate the use of biocides, reduce or eliminate chemical additives, and reduce the overall maintenance cost of water treatment systems, in particular extending the life and reducing fouling of membranes. For more information, go to http://www.symbiosplasma.com/.

About the National Science Foundation's Small Business Programs

The National Science Foundation (NSF) awards nearly $190 million annually to startups and small businesses through the Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) program, transforming scientific discovery into products and services with commercial and societal impact. The non-dilutive grants support research and development (R&D) across all areas of science and technology helping companies de-risk technology for commercial success. The NSF is an independent federal agency with a budget of about $7 billion that supports fundamental research and education across all fields of science and engineering.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Justin Bzdek
@SymbiosPlasma
Follow >
Visit website